P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program

Autor:	F. Tsou, C. Pupareli, B. Bustos, G. Ferreira, J.N. Minatta, G. Roa, C. Novas, M.V. Bluthgen, D. Gomez Bradley, M. Flores, C. Martin, C. Gabay, Eduardo Richardet, Manglio Rizzo, M. Angel, M. Bonet, C. Caglevic, M. Paskevicius, J. Cundom, M. Tatangelo, F. Reinhold, R. Kowalyszyn, A. Pini
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine medicine.medical_specialty Durvalumab Oncology business.industry medicine Locally advanced Medical physics business Real world data
Zdroj:	Journal of Thoracic Oncology. 16:S369
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9800488384b1c9e89347a8c4882a6f90 https://doi.org/10.1016/j.jtho.2021.01.593 Zobrazit plný text záznamu